Pharmacist-Led, Technology-Assisted Study to Improve Medication Safety, Cardiovascular Risk Factor Control, and Racial Disparities in Kidney Transplant Recipients.

ABSTRACT:

Introduction

Health disparities in African-American (AA) kidney transplant recipients compared with non-AA recipients are well established. Cardiovascular disease (CVD) risk control is a significant mediator of this disparity.

Objective

To assess the efficacy of improved medication safety, CVD risk control, and racial disparities in kidney transplant recipients.

Methods

Prospective, pharmacist-led, technology-aided, 6-month interventional clinical trial. A total of 60 kidney recipients with diabetes and hypertension were enrolled. Patients had to be at least one-year post transplant with stable graft function. Primary outcome measured included hypertension, diabetes, and lipid control using intent-to-treat analyses, with differences assessed between AA and non-AA reci

SUBMITTER: Taber DJ 

PROVIDER: S-EPMC6350824 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature